About Medios AG
Medios AG is a publicly listed company based in Berlin (Germany) founded in 2016. It delivers specialty pharmaceuticals and advanced therapies for healthcare stakeholders. It operates on a B2B model. Medios AG has completed 3 acquisitions, including Ceban, Ceban Pharmaceuticals and Medios. Medios AG offers products and services including Specialty Pharma Services and Advanced Therapies. Its focus areas include Specialty Pharma, Drug Supply, Patient-Specific Treatments and Advanced Therapies. Its legal entity is Medios Manufaktur GmbH. Its competitors include Aenova Group and Leukocare; 1 of its 2 listed competitors has raised funding.
Company details
Medios AG, based in Berlin, Germany, is a market leader in Specialty Pharma, ensuring innovative drug therapies reach people across Europe. They offer services from drug supply to patient-specific treatments for pharmacies, doctors, pharmaceutical companies, and clinical study operators. Additionally, they focus on advanced biotechnological precision medicine, emphasizing sustainability and corporate values while serving healthcare professionals and investors.
- Annual Revenue$2.44 B (USD)10.39as on Dec 31, 2025
- Net Profit$18.06 M (USD)22.45as on Dec 31, 2025
- EBITDA$93.52 M (USD)32.99as on Dec 31, 2025
- Investments & AcquisitionsCeban
& 2 more
Products & Services of Medios AG
Medios AG offers a comprehensive portfolio of products and services, including Specialty Pharma Services and Advanced Therapies.
Provides innovative drug therapies for pharmacies and doctors
Offers biotechnological precision medicine solutions
Apps and channels of Medios AG
its YouTube channel Medios has 13 subscribers and 2 videos.
Videos from Medios AG
The most watched videos on Medios AG's YouTube channel, Medios (13 subscribers). Click a video to play it here.
More on Medios.
IPO & Listings of Medios AG
Medios AG is a publicly listed company on the XETR with ticker symbol ILM1 in Germany, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date22 Nov 2016
- Listed onFRA: ILM1
- Listed entityMedios AG
- Exchange sectorDistribution services
- ISINDE000A1MMCC8
- Share price10.42 EUR (+0.97% on the day) · 2026-10-14
- Market capitalisation263,219,044.00 EUR
- Price to earnings22.9
- EPS (diluted, trailing year)0.45 EUR
- Volume (last session)941
Financials of Medios AG
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 2.08B EUR | 15.4M EUR | 79.6M EUR |
| 2024 | 1.88B EUR | 12.6M EUR | 59.8M EUR |
| 2023 | 1.78B EUR | 18.8M EUR | 49.9M EUR |
| 2022 | 1.61B EUR | 18.3M EUR | 49.1M EUR |
| 2021 | 1.36B EUR | 7.4M EUR | 33.0M EUR |
Detailed financial statements for Medios AG
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medios AG
Medios AG has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Ceban, Ceban Pharmaceuticals and Medios.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceutical products are distributed by Ceban Pharmaceuticals. | cebanpharma.com | Breda, Netherlands | 1980 | May 2024 | •••• | |
Compounding pharmacy services are offered independently in Breda. | ceban.nl | Breda, Netherlands | 2004 | Mar 2024 | •••• | |
Diversified drugs are distributed by Blisterzentrum Baden in Germany. | blisterbw.de | Magstadt, Germany | 0 | Nov 2022 | •••• |
Complete acquisition details for Medios AG
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Medios AG
5 dated milestones of Medios AG across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Medios AG is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Medios.
- Acquisition Acquires Ceban.
- Acquisition Acquires Ceban Pharmaceuticals.
Competitors of Medios AG
Medios AG has 2 listed competitors in our database, 1 of them funded. They include Aenova Group and Leukocare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aenova-group.com | 2008 | Starnberg, Germany | CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. | |||
| leukocare.com | 2003 | Munich, Germany | $17.5M | 70 | Proprietary stabilizing solutions for biologics formulations are developed. |
Detailed competitors of Medios AG
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medios Ag
Complete news archive for Medios AG
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medios AG
Medios AG was founded in 2016.
Medios AG is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Annual revenue of Medios AG is $2.44B as on Dec 31, 2025.
Medios AG, based in Berlin, Germany, is a market leader in Specialty Pharma, ensuring innovative drug therapies reach people across Europe. They offer services from drug supply to patient-specific treatments for pharmacies, doctors, pharmaceutical companies, and clinical study operators. Additionally, they focus on advanced biotechnological precision medicine, emphasizing sustainability and corporate values while serving healthcare professionals and investors.
Medios AG's top competitors include Aenova Group and Leukocare.
Medios AG offers Specialty Pharma Services and Advanced Therapies.
Yes, Medios AG is publicly traded on XETR under the ticker symbol ILM1.
Medios AG has made 3 acquisitions, including Ceban, Ceban Pharmaceuticals, and Medios.
Medios AG operates through Medios Manufaktur Gmbh.